NATIONAL HARBOR, Md., May 15, 2015 /PRNewswire/ -- New data from an ongoing post-marketing study evaluating the safety of once-daily XARELTO® (rivaroxaban) in patients with non-valvular atrial fibrillation (NVAF) were presented at the American Geriatrics Society 2015 Annual...
Friday, May 15, 2015
Real-World Data Presented at American Geriatrics Society Meeting Show Consistent Safety of XARELTO® in Elderly Patients
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment